FORLEX

This brand name is authorized in Turkey.

Active ingredients

The drug FORLEX contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII W34SHF8J2K - FORMOTEROL FUMARATE
 

Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge.
 
Read more about Eformoterol
2
UNII S59502J185 - CICLESONIDE
 

Ciclesonide exhibits low binding affinity to the glucocorticoid-receptor. Once orally inhaled, ciclesonide is enzymatically converted in the lungs to the principal metabolite (C21-des-methylpropionyl-ciclesonide) which has a pronounced anti-inflammatory activity and is thus considered as the active metabolite.
 
Read more about Ciclesonide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R03AK Adrenergics and other drugs for obstructive airway diseases R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants
Discover more medicines within R03AK

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
TR İlaç ve Tıbbi Cihaz Kurumu 8680741520351

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈